Raily Aesthetic Medicine International Holdings Limited (2135.HK) HKSE
0.12
-0.001(-0.81%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Raily Aesthetic Medicine International Holdings Limited
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
290
First IPO Date
December 28, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Jianliang Song | CEO, Executive Director & Group President | 694,950 | 1956 |
| Chunxiu Zhang | Group Chief Financial Officer | 510,789 | 1982 |
| Ying Wang | Executive Director & GM of business development department | 606,923 | 1977 |
| Haishu Fu | Founder & Executive Chairman of the Board | 991,463 | 1975 |
| Oi Fat Chan | Company Secretary | 0 | 1978 |
Description
Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services. The company operates through three segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Its services include aesthetic surgery services, including aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, primarily comprising aesthetic injection procedures; aesthetic dermatology services, such as various aesthetic energy-based procedures; and aesthetic medical management consulting services. The company also offers aesthetic dental services, including orthodontics, and dental implant and whitening; and trades in medical equipment. In addition, it sells surgical implants and aesthetic medical skincare products. The company owns and operates a network of four private for-profit aesthetic medical institutions in Zhejiang and Anhui Province, the People's Republic of China. It serves individual retail clients and aesthetic medical institutions. The company was founded in 2008 and is headquartered in Hangzhou, the People's Republic of China. Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.